CLINICAL TRIALS PROFILE FOR SODIUM HEPARIN

All Clinical Trials for Sodium Heparin

Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00000468 ↗	Myocardial Infarction Triage and Intervention Project (MITI)	Completed	National Heart, Lung, and Blood Institute (NHLBI)	Phase 3	1988-04-01	To determine the practicality, benefit, and safety of paramedic administration of thrombolytic therapy for acute myocardial infarction. The feasibility of paramedics correctly identifying candidates for thrombolytic therapy following myocardial infarction was assessed in Phase I. In Phase II, pre-hospital thrombolytic therapy was compared with in-hospital thrombolytic therapy.
NCT00000468 ↗	Myocardial Infarction Triage and Intervention Project (MITI)	Completed	University of Washington	Phase 3	1988-04-01	To determine the practicality, benefit, and safety of paramedic administration of thrombolytic therapy for acute myocardial infarction. The feasibility of paramedics correctly identifying candidates for thrombolytic therapy following myocardial infarction was assessed in Phase I. In Phase II, pre-hospital thrombolytic therapy was compared with in-hospital thrombolytic therapy.
NCT00203580 ↗	Trial of the Effect of Low-Molecular-Weight Heparin (LMWH) Versus Warfarin on Mortality in the Long-Term Treatment of Proximal Deep Vein Thrombosis (DVT) (Main LITE Study)	Completed	Canadian Institutes of Health Research (CIHR)	Phase 4	1994-12-01	The purpose of this study is to assess the long-term treatment of patients with proximal venous thrombosis through the administration of subcutaneous low-molecular-weight heparin (tinzaparin sodium) versus the standard care use of intravenous heparin followed by oral warfarin sodium.
NCT00203580 ↗	Trial of the Effect of Low-Molecular-Weight Heparin (LMWH) Versus Warfarin on Mortality in the Long-Term Treatment of Proximal Deep Vein Thrombosis (DVT) (Main LITE Study)	Completed	Dupont Applied Biosciences	Phase 4	1994-12-01	The purpose of this study is to assess the long-term treatment of patients with proximal venous thrombosis through the administration of subcutaneous low-molecular-weight heparin (tinzaparin sodium) versus the standard care use of intravenous heparin followed by oral warfarin sodium.
NCT00203580 ↗	Trial of the Effect of Low-Molecular-Weight Heparin (LMWH) Versus Warfarin on Mortality in the Long-Term Treatment of Proximal Deep Vein Thrombosis (DVT) (Main LITE Study)	Completed	LEO Pharma	Phase 4	1994-12-01	The purpose of this study is to assess the long-term treatment of patients with proximal venous thrombosis through the administration of subcutaneous low-molecular-weight heparin (tinzaparin sodium) versus the standard care use of intravenous heparin followed by oral warfarin sodium.

Clinical Trial Conditions for Sodium Heparin

Condition Name

Condition Name for Sodium Heparin
Intervention	Trials
Thrombosis	4
Hemodialysis Complication	3
End Stage Renal Disease	3
Healthy	3

Condition MeSH

Condition MeSH for Sodium Heparin
Intervention	Trials
Thrombosis	10
Acute Kidney Injury	6
Venous Thrombosis	6
Renal Insufficiency	5

Clinical Trial Locations for Sodium Heparin

Trials by Country

Trials by Country for Sodium Heparin
Location	Trials
United States	35
Germany	11
Italy	10
Spain	10
Canada	7

Trials by US State

Trials by US State for Sodium Heparin
Location	Trials
New York	6
California	5
Texas	3
Ohio	3
Georgia	2

Clinical Trial Progress for Sodium Heparin

Clinical Trial Phase

Clinical Trial Phase for Sodium Heparin
Clinical Trial Phase	Trials
Phase 4	23
Phase 3	12
Phase 2/Phase 3	6

Clinical Trial Status

Clinical Trial Status for Sodium Heparin
Clinical Trial Phase	Trials
Completed	43
Unknown status	11
Withdrawn	8

Clinical Trial Sponsors for Sodium Heparin

Sponsor Name

Sponsor Name for Sodium Heparin
Sponsor	Trials
Ain Shams University	4
GlaxoSmithKline	4
Azidus Brasil	4

Sponsor Type

Sponsor Type for Sodium Heparin
Sponsor	Trials
Other	116
Industry	27
NIH	3